R Squared’s ProKidney PROK Stock Holding History

R Squared’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.4K	Buy	17,822 +4,126	+30%	+$7.55K	0.02%	463
2026 Q1	$24.5K	Buy	+13,696	New	+$29.1K	0.01%	456

Other funds holding PROK

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

R Squared's PROK Position: Q2 2026 in Review

R Squared increased its ProKidney (PROK) stake by 30% in Q2 2026, buying an estimated $7.55K and bringing the position to 17,822 shares worth $36.4K. The position accounts for 0.02% of the portfolio, ranked #463.

R Squared first reported a position in PROK in Q1 2026 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

R Squared held 17,822 shares of ProKidney worth $36.4K as of Q2 2026.
R Squared bought 4,126 ProKidney shares in Q2 2026, an estimated $7.55K.
ProKidney made up 0.02% of R Squared's portfolio in Q2 2026, its #463 holding.
R Squared first reported a position in ProKidney in Q1 2026 and has held it in 2 quarters since.
71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.